"We are not stopping everything because of the virus": DNB has biotech fund launch on the horizon

In fact, a biotech fund might be a timely addition given the pandemic crisis we are currently facing, DNB Asset Management's Head of Equities says to AMWatch.

Photo: Colourbox

Log in to read our articles

Welcome to AMWatch. A part of our content is exclusive and reserved for our users.

Try AMWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles

amwatch trial

Latest news


See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch